3. Nonspecific Immunomodulation
NPs were used as a cytokine delivery tool, helped modulate physical localization, and served as a repository for sustainable release. The justification was to help effectively manage the nontarget cytotoxicity associated with these treatments.
3.1. Nanomaterials and Immune System Modulations
The sheer quantity of physicochemical properties of NPs, including shape, size, morphology, and elemental constituents, makes the investigation of their cytotoxicity consequences complex and challenging. Oxidative stress, inflammation, genetic damage, cell division, and cell death suppression are paradigms for NP-mediated toxicity. Considerable existing research has revealed that NP cytotoxicity is commonly associated with ROS production (which may be either protective or harmful during biochemical processes), and subsequently, oxidative stress is frequently reported with NPs toxicity
[13][14]. ROS includes superoxide radicals (O
2•), hydrogen peroxide (H
2O
2), hydroxyl radicals (
•OH), and singlet oxygen (
1O
2). Biological systems produce them as metabolic by-products. Adequate oxidative stress is the foundation for many other activities, including induction of protein phosphorylation, multiple transcription factor activation, cell apoptosis, host defense, and differentiation
[14][15]. Intrinsically or externally, ROS can be synthesized inside the cell. Molecular oxygen is generated by O
2•, and primary ROS is mediated by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase through a single electron decrease. Using a metal to speed up the Fenton reaction, a further reduction in oxygen could change H
2O
2 or
•OH into something else
[15][16][16,17].
Inflammatory phagocytes, such as neutrophils and macrophages, generate oxidative outbursts as a defensive mechanism against environmental contaminants, tumor cells, and microorganisms. Intracellular calcium levels activate transcription factors and modulate cytokine synthesis by mechanisms of free radicals and therefore contribute to the influence of NP on oxidative stress
[17][18]. Glutathione-S-transferase (GST) is a phase II enzyme family that catalyzes electrophilic detoxification and protects cells from mutagens, carcinogens, and glutathione, all of which act as free radical scavengers. GST in the cytosol eliminates H
2O
2. GST interacts with H
2O
2 in a glutathione peroxidase catalyzed chemical reaction that results in glutathione disulfide (GSSG). Glutathione reductase (GR) catalyzes GSSG glutathione regeneration using the NADPH hexose monophosphate shunt (HMPS) produced by NADPH
[18][19].
NP-mediated ROS responses orchestrate a cascade of adverse pathological processes such as inflammation, genotoxicity, fibrosis, and carcinogenesis. Nanomaterials with different chemical compositions, such as fullerenes, CNTs, and metal oxides, have been reported to promote ROS. The major variables in NP-induced ROS are (i) active redox cycling on the surface of NP due to transition metal-based NP, (ii) surface functional groups, and (iii) NPs–cell interactions
[19][20]. Furthermore, CNT-induced oxidative stress, for example, promotes cellular signaling pathways, increasing the production of pro-inflammatory cytokines. Some NPs have been shown to activate inflammatory cells, such as macrophages and neutrophils, increasing ROS production. Several NPs, such as titanium dioxide (TiO
2), zinc oxide (ZnO), cerium oxide (CeO
2) and silver NP, have been documented to deposit on the cellular surface or even inside intracellular organelles and trigger oxidative stress signaling cascades, resulting in oxidative damage to the cell
[20][21]. Because of their surface characteristics, NPs, such as Si and Zn with identical particle sizes and shapes, exhibit varied cytotoxicity responses. Since ZnO is more chemically active than SiO
2, it generates more free radicals, leading to increased oxidative stress
[21][22]. The process of ROS formation differs for each NP, and the precise underlying cellular mechanism for ROS generation is still unknown and must be explored
[22][23].
3.2. Immunological Effects of Nanomaterials (Immunotoxicology)
When used in vivo, NPs and the interface between the NP and the biological material play a key role in how the nanomaterial is transported, eliminated, and deposited, especially when it comes to the systemic administration of medicines. A protein crown effect, also known as a protein corona particle, is formed when NPs encounter biofluids for the first time. The way in which NPs interact with plasma proteins and other biomolecules changes their bioactivity, which in turn causes several changes in the way the body works. When the immune system encounters a foreign body, such as NPs, the first cells to respond are phagocytic cells. Several conditions, including inflammation, are caused by overactive immune systems, whereas immunosuppression leaves the host susceptible to infections by the inhalation of CNTs was used to decrease B cell activity via NP involvement in immunosuppression
[23][24]. The alveolar macrophage produced is important for the immunosuppressive process observed. When the immune system encounters a foreign body, such as NPSs, the first cells to respond are phagocytic cells. There have been several reports of negative interactions between the immune system and nanoparticles, with immune stimulator immunosuppression potentially leading to inflammatory or autoimmune diseases and increasing the receptor likelihood that the body will get infected. Immunosuppressive NPs were used to reduce B cell activity by allowing people to breathe in CNTs. However, when a nanomaterial is administered subcutaneously or intradermally, stimulation of the complement system by NPs can improve the effectiveness of the treatment. Modifying the physicochemical features of NPs allows for control over the pathways by which they activate the complement system. After being exposed to nanoparticles, important biological processes happen, and mast cells play a role in inflammation and the toxicity of some NPs
[24][25][25,26].
3.3. Mechanism of Nanomaterials Toxicity
Direct or indirect modulation of oxidative enzymatic reactions by NPs causes oxidative stress because of free radicals, or ROS, such as superoxide anions and hydroxyl radicals. Multiple factors contribute to oxidative stress in the body. Cellular responses to nanoparticles are accompanied by the production of ROS, which can be stimulated by the oxidant characteristics of the particles themselves. Free radical intermediates are present on the reactive surfaces of particles and are quite stable; however, there are effects of NP functionalities on the formation of redox-active groups. A summary of the influence (immunogenicity, antigenicity, clearance, immunostimulation, and immunosuppression) of nanomaterials on the immune system is shown in
Figure 2.
Figure 2. Schematic illustration of the major influence of nanomaterials on the immune system. Nanomaterials can induce immunogenicity, which is the ability of NPs to induce humoral or cell-mediated immune responses, whereas the antigenicity effect of NPs deals with the ability of such materials to react with antibodies or T cells. NPs could be engineered to avoid interactions with the immune system or specifically interact with the immune system to simulate or suppress their effects. In some cases, the immune system stimulation generated by such NPs could manifest as a hypersensitivity reaction, anaphylactic shock, or inflammation. In immunosuppression, NPs can have a stimulating effect on immune system components, such as APCs, B cells, and T cells, directly or indirectly. The degradation and clearance of NPs are the main factors contributing to the use of such materials in clinical settings. Tiny NPs below 10 nm are rapidly excreted by the kidney and liver. Particles larger than 100 nm can be eliminated by the mononuclear phagocytic system, such as the lymph nodes and spleen. The image was generated by BioRender.
3.4. Nanomaterials Affect Cell Functions
The practical problem of immunosuppression and immunostimulants mediated by NPs is highly innovative, as the interaction of NPs with the body’s immune system and their impact have not been fully understood; nevertheless, there is a considerable amount of evidence that illustrates the enormous potential of these immunomodulation strategies for the treatment of immunological disorders. The use of NPs and the modulation of immunostimulants and immunosuppression are summarized in
Table 1.
Table 1.
Immune system modulation by NPs.
3.5. Immunosuppression
Immunosuppression occurs when a medication or other substance inhibits the activation or effectiveness. Immunosuppression is commonly thought to be an immunotoxic impact linked to various human diseases. The size, morphology, and composition facilitate blood, cellular, and protein adsorption, allowing for more efficient interactions with immune cells and the subsequent immunological response. AuNPs are an excellent example of these effects. Larger AuNPs and rod-shaped geometries are routinely internalized via sophisticated uptake mechanisms. Spherical NPs between 5 and 30 nm in diameter are susceptible to passive association with cells. The surface coating does have an impact on their absorption by cells. For example, citrate or lipid capping of the AuNPs may increase the particles’ stability and passive intake
[32][33][33,34]. On the other hand, since silver and gold NPs interact with adaptive and innate immune systems, few studies have elucidated the mechanism behind the potential of noble metal NPs to induce an immunosuppressive response
[34][35]. Citrate-coated AuNPs have been shown to have no measurable cellular or organ toxicity in mice. However, researchers reported anti-inflammatory potential that reduced cellular responses triggered by interleukin 1 beta (IL-1β). IL-1 β is an inflammatory cytokine that mediates adaptive immune responses, as well as common inflammatory conditions such as rheumatoid arthritis
[35][36][36,37]. The potential of monodispersed citrate-coated AuNPs varying in size from 5 to 35 nm to regulate pro-inflammatory functionality induced by IL-1β generation was examined. The IL-1β pathway disrupted the smallest nanoparticles, measuring 5 nm. Larger nanoparticles (>10 nm) had less of an impact, while 35 nm particles did not affect the IL-1 pathway
[37][38]. Furthermore, poly(acrylic acid)-coated AuNPs have been shown to have opposite effects in the same THP-1 cell lines by promoting inflammation
[38][39].
Immunosuppression produced by AgNPs has received less attention than AuNPs. Silver nanoparticles stimulated the production of TNF-, IL-6, IL-8, IL-1, and IL-11 production
[39][40]. Tian et al. demonstrated that topical treatment of AgNPs modulated cytokines at a wound site. IL-6 mRNA expression was considerably reduced during the healing phase, whereas TGF-1 expression increased. It has also been demonstrated that local and systemic applications can reduce inflammation
[40][41]. In addition, iron oxide NPs have been shown to induce immunosuppression and anti-inflammatory activities. Ovalbumin-sensitized mice received ovalbumin, a T cell-dependent antigen, after an administration of iron oxide nanoparticles in investigations by Liao et al. and Shen et al. Antigen-specific antibody expression, as well as antigen-specific cytokine secretion in the spleen, was considerably decreased. Iron oxide nanoparticles inhibited the activity of T helper cells and macrophages while decreasing interferon, IL-6, and TNF-expression
[41][42][42,43]. TNF- and IL-6 are both cytokines that contribute to inflammatory responses. Iron oxide NPs also changed the proportion of helper T cells, suppressing the allergic response. In an alternative animal model, administration of iron oxide particles preceding immunological activation with an endotoxin lowered IL-1 expression in microglia cells. Iron oxide NPs hindered cytokine processing pathways, culminating in the attenuation of IL-1. Human dendritic cells treated with poly(vinyl alcohol)-coated iron oxide NPs exhibited impaired antigen processing and T cell activation in a separate study. Injections of iron oxide nanoparticles were given again, and the inflammation was reduced
[43][44]. According to Jan et al.
[44][45], iron oxide NPs accumulated in lysosomes, improving lysosomal accessibility, and reducing cathepsin B activity.
Furthermore, cerium can consistently switch redox potential between Ce
4+ and Ce
3+, allowing cerium oxide NPs to absorb reactive oxygen species efficiently. As cerium oxide switches between oxidation states, it creates oxygen vacancies in the crystal lattice. Since the vacancies are clustered at the NPs’ surfaces, cerium oxide NPs have a high capability to interact with free radicals immediately. This antioxidant potential has been demonstrated in several studies
[44][45]. Cerium oxide NPs antioxidant properties allow them to suppress inflammation caused by nitric oxide synthase production
[45][46]. Superoxide dismutase-2, an oxidative stress mediator, was also upregulated by cerium oxide NPs. The antioxidant properties of cerium oxide NPs, similar to those of many other NPs, are influenced by their size and morphology. As a result, smaller cerium oxide NPs outperformed their larger counterparts in antioxidant capacity.
Figure 3 summarizes the various effects of the NPs on different immune cells, depending on whether immunosuppressive or inflammatory cytokines are secreted.
Figure 3. Schematic illustration of the NPs interaction and effect on the immune system. NPs (metalic, polymeric, dendrimer, carbon-based and lipid-based) interact with immune cells such as antigen-presenting cells, B cells, T cells, and macrophages. For example, carbon-based nanomaterials are involved in up-regulation of transforming growth factor (TGF-β), interleukin-10 (IL-10), and it also decreased B cell activity in addition to apoptosis. Metal oxide NPs have also been reported to affect adaptive immune cells, such as cerium oxide NPs, which are responsible for scavenging reactive oxygen species (ROS). Polymeric NPs and dendrimers exhibit an assortment of immunosuppressive effects. Some possible mechanisms by which various nanoscale compounds might dampen the immune system are illustrated.
Polymer NPs and macromolecules (dendrimers) exhibit an assortment of immunosuppressive effects. Some possible mechanisms by which various nanoscale compounds might dampen the immune system are illustrated. Fullerenes (C60), such as cerium oxide NPs, efficiently reduce oxidative stress by lowering ROS levels. Compared to cerium oxide NPs, fullerenes disseminate reactive oxygen species via their aromatic structure. Fullerenes reduce both hydroxyl and superoxide oxygen radicals, and many of their free radical-scavenging abilities have been regulated by bioconjugation of fullerenes with water-soluble ligands
[46][47][47,48]. Fullerenes have been reported in vitro and in vivo to suppress oxidative stress, even though the immune response is strongly dependent on administration and dosing. The administration of low doses of fullerenes by intraperitoneal administration or inhalation significantly reduced oxidative stress
[48][49]. Hydroxylated fullerenes have been used to protect RAW 264.6 cells against oxidative stress in vitro and ischemia-perfused lungs in rats. Fullerenes can inhibit the release of human mast cells and peripheral blood basophils by reducing the signaling pathways associated with oxygen radical quantities
[49][50]. Basophils and mast cells are essential in inflammatory responses, including type I hypersensitivity reactions. Type I hypersensitivity responses are usually triggered by persistent exposure to the allergen. B cells produce allergen-specific immunoglobulin E (IgE), which binds to receptors and sensitizes mast cells or basophils upon first allergen exposure. Following exposure to the allergen, IgE crosslinks and mediators, including prostaglandins and histamine, are activated. Basophils and mast cells lowered IgE signaling and ROS formation following fullerene administration, preventing the release of histamine
[50][51].
Furthermore, Mitchell et al. revealed that inhaling multi-walled carbon nanotubes (MWCNTs) in tiny amounts stimulated T-cell dysfunction pathways that suppressed the immunological response from splenic lymphocytes, but there was no toxicity or immunosuppressive action in the lungs. Exposure to MWCNT significantly reduced natural killer cellular activities, increased prostaglandin synthesis, and increased IL-10 production
[51][52]. In contrast, single-walled carbon nanotubes (SWCNTs) have been shown to repress immune system mediators in human lung epithelial cells. Additional investigations found that inhalation of SNCNTs increased lung inflammatory responses and decreased T cell responsiveness after exposure in mouse models; this immunosuppression seemed related to the direct effects on dendritic cells
[52][53]. The observed differences in immunological response between fullerenes, MWCNTs, and SWCNTs may be attributed to their complex geometries and electrochemical properties. Research to unravel these effects in the future could contribute to a better understanding of the implications of surface charge and intrinsic conductivity on the immune system response
[53][54][54,55].
Polystyrene latexes are one form of polymeric NPs that are studied for an immunological response. Polystyrene latexes were shown to produce immunosuppressive and immunostimulatory impacts. Polystyrene NP suppressed lung inflammation after allergen exposure, which was ascribed to inhibition of dendritic cell expansion within the lungs
[49][50]. Another investigation employing polystyrene nanoparticles highlighted the significant impact of surface charge on the immune response. By coating polystyrene nanoparticles with charged sulfonate and phosphonate groups, Frick et al. altered their surface properties. This caused dendritic cell maturation and increased CD4+ T cell activity, resulting in immunostimulant activity
[55][56]. Finally, by inactivating pathogenic T cells, antigen-decorated polystyrene NPs induced T-cell tolerance and suppressed autoimmune encephalomyelitis. This considerable effect of surface groups on the immunological response of basic polystyrene nanoparticles emphasizes the need for a comprehensive study of the immunology of polymer nanoparticles, which are often commended or promoted for the delivery of drugs and other nanomedicine purposes
[56][57].
The anti-inflammatory activities of polyamidoamine dendrimers were established by chance while studying their potential as a drug delivery system. Polyamidoamine dendrimers with amine or hydroxyl surface functional groups significantly suppressed pro-inflammatory activities. Dendrimers with carboxylate surface groups had no significant anti-inflammatory effects. In microglia cells, hydroxyl-terminus polyamidoamine dendrimers also inhibited the secretion of pro-inflammatory regulators such as nitric oxide and IL-6
[57][58]. Hayder et al. likewise utilized anionic azabisphosphonate moieties to alter the surface charge of dendrimers. These anionic dendrimers were administered to arthritic mouse models and suppressed the release of pro-inflammatory cytokines and the osteoclastogenesis pathway
[58][59].
Further, polyamidoamine-glucosamine dendrimers have been proven to block TLR-mediated inflammatory responses and diminish IL-6 and IL-8 release
[59][60]. Imidazoquinoline-based dendrimers with imidazoquinoline as the core ingredient rather than glucosamine are analogous to polyamidoamine-glucosamine dendrimers. Because imidazoquinoline is a TLR7 and TLR8 agonist, imidazoquinoline-based dendrimers inhibit TLR7 and TLR8 activities
[60][61]. This shows that the surface charge is pretty simple and that changing the chemistry of the surface could be used to make NPs that precisely modulate the innate immune response.
Liposomes can also be utilized to improve the localization of immunosuppressant drugs that have been entrapped. Hong et al. and others investigated the effectiveness of encapsulating IL-10 genes in cationic liposomes to enhance allograft survival after a heart transplant. Liposome administration led to local overexpression of IL-10 and a decline in lymphocyte reactivity. Similarly, after a liver transplant, canines received liposomal tacrolimus, an immunosuppressive treatment, and survived substantially longer than dogs who received tacrolimus intravenously
[61][62][62,63]. When used to treat rheumatoid arthritis in rats, glucocorticoids incorporated within liposomes result in much less cytotoxicity and enhanced inhibition of anti-inflammatory cytokines than free drug administration
[63][64][64,65].
3.6. Immunostimulant
The propensity of NPs to induce innate or adaptive immune responses is being used to assess their immunostimulatory potential as summarize in
Table 2. The stimulation of the complement cascade can be detrimental if particles penetrate the systemic circulation accidentally or on purpose, resulting in hypersensitivity responses and anaphylaxis
[65][66]. The size has been proposed to be an important factor in determining whether antigens loaded into nanoparticles produce type I (interferon-) or type II (IL-4) cytokines, thus contributing to the type of stimulatory immune response
[66][67].
Induction of allergic responses is one aspect of NP-mediated immunostimulation. A few investigations have connected NP exposure to allergy responses in test animals and humans. In mice, for example, SWCNT and MWCNTs equally increased the allergenicity of egg albumin, whether administered by intranasal or subcutaneous injection routes. The CNT-mediated activation of the acute inflammatory response is hypothesized to be the mechanism underlying this enhanced allergenicity
[67][68].
In rare circumstances, nanoformulation of an authorized treatment would prevent allergic responses linked to previously approved preparations, and abraxane is an illustration of this reformulation. In this instance, reconstituted paclitaxel-bound albumin nanoparticles provoked no allergic response, but the first-generation formulations of paclitaxel in the non-ionic surfactant Cremophor EL triggered significant hypersensitivity, commonly involving premedication with only steroids and a histamine blocker
[68][69]. Almost all the immunostimulatory responses elicited by nanoparticles are mediated by the release of pro-inflammatory cytokines. Numerous studies have provided evidence through various forms of nanomaterials that can induce cytokine production, i.e., AuNPs, lipid-based NPs, dendrimers, etc.
[69][70][71][70,71,72].
The diameter of NPs has been perceived as a determinant factor in influencing an NP’s ability to generate cytokine activation. For example, CNT length has been reported to correlate with in vivo subcutaneous injection inflammation caused by CNT administration
[72][73]. On the contrary, some studies have demonstrated that surfactants or microbial endotoxins included in the formulations, rather than NPs, trigger cytokine production. As a result, when analyzing the inflammatory properties of NPs, it is vital to evaluate the levels of chemical (byproduct generation) and biological (endotoxin) components.
Table 2.
NP-based immunostimulatory effect and study results from the studies outcome.